Post

Amplia reports AMP945 data in preclinical model of pancreatic cancer

Amplia Therapeutics has reported data demonstrating the efficacy of AMP945 in a preclinical model of pancreatic cancer when used along …

Abbisko reports updated results from TGCT Phase Ib study

Abbisko Therapeutics has reported updated results from a Phase Ib study of Pimicotinib (ABSK021) for the treatment of advanced tenosynovial …

AstraZeneca reports positive results from endometrial cancer therapy trial

AstraZeneca has reported positive high-level results from the DUO-E trial (GOG 3041/ENGOT-EN10) of Imfinzi (durvalumab) and platinum-based chemotherapy combination followed …

Harbour reports results from HCC combo therapy trial

Harbour BioMed has reported results from a Phase Ib clinical trial of porustobart (HBM4003) combined with toripalimab for the treatment …

I-Mab reports encouraging data from Phase Ib/II NSCLC combo therapy trial

I-Mab has reported encouraging data from the Phase Ib/II study evaluating uliledlimab combined with toripalimab (TUOYI) in patients with treatment-naïve …